Please assess the completion status of the following clinical trial:

Trial Title: Chalazion Conservative Treatment Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria~* Patients age 18 and above~* Patient with a palpable chalazion on any eyelid~* Patients with multiple chalazia but only a single one on each lid~* Normal lid anatomy enabling lid eversion~Exclusion Criteria~* Patients with chalazia with atypical features (recurring chalazion, abnormal surrounding lid tissue, associated loss of lashes) that may indicate suspicion of malignancy~* Patients allergic to any agents being used in the study (tobramycin, dexamethasone)~* Patients who have had previous eyelid surgery to the same eyelid as the chalazion~* Patients under 18 years of age~* Patients without palpable lid chalazion~* Patients with multiple chalazia on one eyelid~* Patients with concurrent eyelid infection (cellulitis or conjunctivitis)~* Patients unable to give consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hot Compress (Type: ACTIVE_COMPARATOR): Hot Compress
- Tobrex (Type: ACTIVE_COMPARATOR): Hot Compress, Tobrex Drops, Tobrex Ointment
- Tobradex (Type: ACTIVE_COMPARATOR): Hot Compress, Tobradex Drops, Tobradex Ointment

Based on this trial design, predict the completion outcome and termination type (if applicable).